2020-02-20T11:41:00+00:00By Dr David Spraggett
Dr David Spraggett outlines five key learning points to take away from the 2019 NICE guideline on cannabis-based medicinal products
2020-01-24T09:15:00+00:00By Professor Niroshan Siriwardena
Professor Niroshan Siriwardena highlights the relevant recommendations for primary care from the British Association of Psychopharmacology guideline on insomnia and sleep disorders
2019-08-14T10:21:00+01:00By Dr Ivan Benett
Dr Ivan Benett identifies five key learnings for primary care from the new NICE guideline on stroke and transient ischaemic attack (TIA)
2018-07-26T08:35:00+01:00By Dr Caroline Rayment
Dr Caroline Rayment discusses how the new NICE guideline will help practitioners provide early and consistent treatment to patients with suspected Lyme disease
Dr Natasha Halliwell examines the latest recommendations from NICE on recognising, treating, and managing attention deficit hyperactivity disorder
More neurology articles
More from Guidelines Learning
Thu, 09 Jul 2020 00:00:00 GMT
A brief NICE guidance summary relevant to primary care about diagnosis of MS, support for patients, and modifiable risk factors for relapse and progression.
Mon, 22 Jun 2020 13:05:00 GMT
A useful summary on how GPs can help diagnose and manage the after-effects of acute brain injury in adults and children, including encephalitis.
Thu, 04 Jun 2020 00:00:00 GMT
A brief, helpful summary of the diagnosis and management of epilepsy in adults and children. Includes status epilepticus management, review, and referral.
Fri, 20 Dec 2019 15:36:00 GMT
This Guidelines summary covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.
Tue, 03 Jul 2018 08:23:00 GMT
Summary of the NICE dementia guidance covers diagnosis in non-specialist settings, pharmacological management, and managing non-cognitive symptoms.
Site powered by Webvision Cloud